Supporting oncology professionals through education

The content on this site is intended for healthcare professionals only

News [3692]

$ASH 2021: TRANSFORM study reports CAR T-cell therapy liso-cel significantly improves outcomes for relapsed and refractory large B-cell lymphoma$

ASH 2021: TRANSFORM study reports CAR T-cell therapy liso-cel significantly improves outcomes for relapsed and...

Smart transformable nanoparticles promise advances in tumour diagnoses and treatment

Smart transformable nanoparticles promise advances in tumour diagnoses and treatment

Talk between immune cells could lead to new cancer vaccine

Talk between immune cells could lead to new cancer vaccine

CRISPR/Cas9 gene editing boosts effectiveness of ultrasound cancer therapy

CRISPR/Cas9 gene editing boosts effectiveness of ultrasound cancer therapy

Comprehensive multi-omics analysis categorises distinct pathogenic processes in CLL

Comprehensive multi-omics analysis categorises distinct pathogenic processes in CLL

Which glioblastoma patients will respond to immunotherapy?

Which glioblastoma patients will respond to immunotherapy?

Sequencing of bone marrow DNA may predict leukaemia relapse after CAR-T therapy with sufficient time to intervene

Sequencing of bone marrow DNA may predict leukaemia relapse after CAR-T therapy with sufficient time to intervene

Chemotherapy may affect muscle cells at lower doses than previously thought

Chemotherapy may affect muscle cells at lower doses than previously thought

Shape-morphing microrobots deliver drugs to cancer cells

Shape-morphing microrobots deliver drugs to cancer cells

FDA approves pembrolizumab for adjuvant treatment of renal cell carcinoma

FDA approves pembrolizumab for adjuvant treatment of renal cell carcinoma

More from ecancer